Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May 28;113(22):5680-8.
doi: 10.1182/blood-2008-08-174508. Epub 2009 Jan 14.

DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries

Affiliations
Free article

DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries

Inga Sörensen et al. Blood. .
Free article

Abstract

Notch signaling has been shown to regulate various aspects of vascular development. However, a specific role of the ligand Delta-like 1 (DLL1) has not been shown thus far. Here, we demonstrate that during fetal development, DLL1 is an essential Notch ligand in the vascular endothelium of large arteries to activate Notch1 and maintain arterial identity. DLL1 was detected in fetal arterial endothelial cells beginning at embryonic day 13.5. While DLL4-mediated activation has been shown to suppress vascular endothelial growth factor (VEGF) pathway components in growing capillary beds, DLL1-Notch signaling was required for VEGF receptor expression in fetal arteries. In the absence of DLL1 function, VEGF receptor 2 (VEGFR2) and its coreceptor, neuropilin-1 (NRP1), were down-regulatedin mutant arteries, which was followed by up-regulation of chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), a repressor of arterial differentiation and Nrp1 expression in veins. Consistent with a positive modulation of the VEGF pathway by DLL1, the Nrp1 promoter contains several recombinant signal-binding protein 1 for J kappa (RBPJkappa)-binding sites and was responsive to Notch activity in cell culture. Our results establish DLL1 as a critical endothelial Notch ligand required for maintaining arterial identity during mouse fetal development and suggest context-dependent interrelations of the VEGFA and Notch signaling pathways.

PubMed Disclaimer

Comment in

Similar articles

Cited by

  • Genetic Tools to Study Cardiovascular Biology.
    Garcia-Gonzalez I, Mühleder S, Fernández-Chacón M, Benedito R. Garcia-Gonzalez I, et al. Front Physiol. 2020 Sep 24;11:1084. doi: 10.3389/fphys.2020.01084. eCollection 2020. Front Physiol. 2020. PMID: 33071802 Free PMC article. Review.
  • Notch signaling in lung diseases: focus on Notch1 and Notch3.
    Zong D, Ouyang R, Li J, Chen Y, Chen P. Zong D, et al. Ther Adv Respir Dis. 2016 Oct;10(5):468-84. doi: 10.1177/1753465816654873. Epub 2016 Jul 4. Ther Adv Respir Dis. 2016. PMID: 27378579 Free PMC article. Review.
  • Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells.
    Wang Y, Cao Y, Mangalam AK, Guo Y, LaFrance-Corey RG, Gamez JD, Atanga PA, Clarkson BD, Zhang Y, Wang E, Angom RS, Dutta K, Ji B, Pirko I, Lucchinetti CF, Howe CL, Mukhopadhyay D. Wang Y, et al. J Cell Sci. 2016 Oct 15;129(20):3911-3921. doi: 10.1242/jcs.190702. Epub 2016 Sep 2. J Cell Sci. 2016. PMID: 27591257 Free PMC article.
  • MFSD7c functions as a transporter of choline at the blood-brain barrier.
    Nguyen XTA, Le TNU, Nguyen TQ, Thi Thuy Ha H, Artati A, Leong NCP, Nguyen DT, Lim PY, Susanto AV, Huang Q, Fam L, Leong LN, Bonne I, Lee A, Granadillo JL, Gooch C, Yu D, Huang H, Soong TW, Chang MW, Wenk MR, Adamski J, Cazenave-Gassiot A, Nguyen LN. Nguyen XTA, et al. Cell Res. 2024 Mar;34(3):245-257. doi: 10.1038/s41422-023-00923-y. Epub 2024 Feb 2. Cell Res. 2024. PMID: 38302740 Free PMC article.
  • IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption.
    Langer V, Vivi E, Regensburger D, Winkler TH, Waldner MJ, Rath T, Schmid B, Skottke L, Lee S, Jeon NL, Wohlfahrt T, Kramer V, Tripal P, Schumann M, Kersting S, Handtrack C, Geppert CI, Suchowski K, Adams RH, Becker C, Ramming A, Naschberger E, Britzen-Laurent N, Stürzl M. Langer V, et al. J Clin Invest. 2019 Nov 1;129(11):4691-4707. doi: 10.1172/JCI124884. J Clin Invest. 2019. PMID: 31566580 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances